The low frequency of beta-catenin mutations in cell lines established from human colorectal cancers

The low frequency of beta-catenin mutations in cell lines established from human colorectal cancers

Detalhes bibliográficos
Principais autores:	Ilyas, M, Tomlinson, I, Rowan, A, Pignatelli, M, Bodmer, W
Formato:	Journal article
Publicado em:	1997

Registros relacionados

Beta-catenin mutations in cell lines established from human colorectal cancers.
por: Ilyas, M, et al.
Publicado em: (1997)

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.
por: Bicknell, D, et al.
Publicado em: (1994)

Loss of heterozygosity at APC and beta-catenin expression in sporadic colorectal carcinogenesis
por: Hao, X, et al.
Publicado em: (1998)

Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
por: Hao, X, et al.
Publicado em: (2002)

Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours.
por: Hao, X, et al.
Publicado em: (1997)

Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines.
por: El-Bahrawy, M, et al.
Publicado em: (2004)

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.
por: Mann, B, et al.
Publicado em: (1999)

E-cadherin mutations in human colorectal cancer cell lines
por: Wheeler, J, et al.
Publicado em: (1999)

E-cadherin mutations in human colorectal cancer cell lines
por: Wheeler, J, et al.
Publicado em: (1999)

The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.
por: Ilyas, M, et al.
Publicado em: (1997)

Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours.
por: Homfray, T, et al.
Publicado em: (1998)

APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
por: Rowan, A, et al.
Publicado em: (2000)

APC mutations are sufficient for the growth of early colorectal adenomas.
por: Lamlum, H, et al.
Publicado em: (2000)

Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
por: Johnson, V, et al.
Publicado em: (2005)

Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.
por: Efstathiou, J, et al.
Publicado em: (1998)

Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
por: Beck, N, et al.
Publicado em: (1997)

Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
por: Hao, X, et al.
Publicado em: (1997)

Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.
por: Ilyas, M, et al.
Publicado em: (1999)

TP53 and Beta-catenin mutations in liver tumours
por: Pierre Hainaut
Publicado em: (2007-02-01)

Genetic pathways in colorectal and other cancers.
por: Ilyas, M, et al.
Publicado em: (1999)

Genetic pathways in colorectal and other cancers.
por: Ilyas, M, et al.
Publicado em: (1999)

Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy.
por: Browning, M, et al.
Publicado em: (1993)

Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice.
por: Wilding, J, et al.
Publicado em: (2002)

Diagnostic Utility of Beta-Catenin in Poorly Differentiated Colorectal Carcinoma
por: Farukh Mir Muhammad, et al.
Publicado em: (2023-12-01)

The destruction complex of beta-catenin in colorectal carcinoma and colonic adenoma
por: Guilherme Muniz Bourroul, et al.

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.
por: Bicknell, D, et al.
Publicado em: (1996)

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
por: Liu, Y, et al.
Publicado em: (2006)

The majority of β-catenin mutations in colorectal cancer is homozygous
por: Alexander Arnold, et al.
Publicado em: (2020-10-01)

Nuclear beta-catenin expression and Wnt signalling: in defence of the dogma.
por: Fodde, R, et al.
Publicado em: (2010)

ABNORMALITIES IN HLA EXPRESSION ON COLORECTAL TUMOR-CELL LINES - IMPLICATIONS FOR ANTIGEN PRESENTATION
por: Browning, M, et al.
Publicado em: (1993)

Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas
por: Douglas, E, et al.
Publicado em: (2004)

Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas.
por: Douglas, E, et al.
Publicado em: (2004)

Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.
por: Tomlinson, I, et al.
Publicado em: (1996)

Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
por: He K, et al.
Publicado em: (2023-05-01)

Subcellular Localization of Beta Catenin in Colorectal Non Neoplastic and Neoplastic Lesions
por: Diah Rini Handjari, et al.
Publicado em: (2012-01-01)

"Null" HLA A*0101 mutation identified in a colorectal cancer cell line
por: Bicknell, D, et al.
Publicado em: (2001)

A mutated HLA-A*0101 allele in the colorectal cell line HCA-7.
por: Bicknell, D, et al.
Publicado em: (2005)

Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.
por: Halford, SE, et al.
Publicado em: (2003)

Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors.
por: Maretto, S, et al.
Publicado em: (2003)

Mutations in Bcl10 are very rare in colorectal cancer.
por: Stone, J, et al.
Publicado em: (1999)